A STUDY IN PATIENTS WITH NEOVASCULAR AGE RELATED MACULAR DEGENERATION OR MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TO EVALUATE USABILITY OF THE RANIBIZUMAB (LUCENTIS®) PREFILLED SYRINGE (PFS):